TLDR Myo-inositol and D-chiro-inositol, especially in a 40:1 ratio, effectively treat PCOS by improving insulin sensitivity and ovulation.
The review examines the use of myo-inositol (MYO) and D-chiro-inositol (DCI) for treating polycystic ovary syndrome (PCOS), finding that MYO alone and in combination with DCI at a 40:1 ratio are effective, particularly for improving insulin sensitivity, ovulatory function, and oocyte quality. A meta-analysis of nine clinical trials involving 247 PCOS patients supports the efficacy and safety of these treatments compared to traditional options like metformin. The review suggests that while the 40:1 ratio is effective, further research into higher MYO ratios, such as 66:1 to 100:1, could enhance treatment outcomes. Maintaining a proper inositol ratio is crucial, as higher DCI concentrations can negatively impact reproductive outcomes.
2 citations
,
January 2022 in “Springer eBooks”
54 citations
,
August 2017 in “Gynecological Endocrinology” Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.
200 citations
,
October 2009 in “European journal of endocrinology” Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.
36 citations
,
May 2021 in “Nutrients” Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.
August 2015 in “Evidence Based Women Health Journal (Online)” Inositol was more effective than Metformin in treating symptoms of PCOS in women.
March 2024 in “Romanian Medical Journal” Inositol shows promise in treating PCOS and other health issues, but more research is needed.
May 2022 in “Maǧallaẗ Buḥūṯ Al-Tarbiyyaẗ Al-Nawʿiyyaẗ (Print)” Eating a high inositol diet significantly improves insulin resistance and hormone levels in women with PCOS.
24 citations
,
July 2019 in “Journal of Obstetrics and Gynaecology” The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.
44 citations
,
September 2020 in “International Journal of Molecular Sciences” New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.